Disparities in ovarian cancer care quality and survival according to race and socioeconomic status

Journal of the National Cancer Institute

Volumn 105, Issue 11, 2013, Pages 823-832

  Bristow, Robert E ^a   Powell, Matthew A ^b   Al Hammadi, Noor ^c   Chen, Ling ^c   Miller, J Philip ^c   Roland, Phillip Y ^d,e   Mutch, David G ^b   Cliby, William A ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Division of Gynecologic Oncology   (United States)

^c St Louis School of Medicine   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e SAINT FRANCIS HOSPITAL AND MEDICAL CENTER   (United States)

^f MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AFRICAN AMERICAN; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEALTH CARE DISPARITY; HEALTH CARE QUALITY; HUMAN; INCOME; MAJOR CLINICAL STUDY; MEDICAID; MEDICAL RECORD REVIEW; MEDICALLY UNINSURED; MEDICARE; OUTCOME ASSESSMENT; OVARY CARCINOMA; OVERALL SURVIVAL; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE DIFFERENCE; SOCIAL STATUS;

ADULT; AFRICAN AMERICANS; AGED; ANTINEOPLASTIC AGENTS; CARCINOMA; CHEMOTHERAPY, ADJUVANT; CONFOUNDING FACTORS (EPIDEMIOLOGY); DRUG PRESCRIPTIONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GUIDELINE ADHERENCE; HEALTHCARE DISPARITIES; HUMANS; INSURANCE, HEALTH; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MEDICAID; MEDICARE; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PRACTICE GUIDELINES AS TOPIC; QUALITY OF HEALTH CARE; SOCIAL CLASS; UNITED STATES;

EID: 84878880984     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djt065     Document Type: Article

References (40)

1. Institute of Medicine. The Unequal Burden of Cancer. Washington, DC: National Academy Press; 1999.
2. Institute of Medicine. Unequal Treatment: Confronting Racial and Ethnic Disparities in Healthcare. Washington, DC: National Academy Press; 2003.
3. Harlan LC, Greene AL, Clegg LX, Mooney M, Stevens JL, Brown ML. Insurance status and the use for guideline therapy in the treatment of selected cancers. J Clin Oncol. 2005;23(36):9079-9088.
4. Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287(16):2106-2113. (Pubitemid 34437345)
5. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011. The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA J Clin. 2011;61(4):212-236.
6. Jemal A, Siegel R, Ward E, et al. Cancer statistics 2006. CA J Clin. 2006;56(2):106-130.
7. Barnholtz-Sloan JS, Schwartz AG, Qureshi F, Jacques S, Malone J, Munkarah AR. Ovarian cancer: changes in patterns at diagnosis and relative survival over the last three decades. Am J Obstet Gynecol. 2003;189(4);1120-1127. (Pubitemid 37373908)
8. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics. CA J Clin. 2009;59(4):225-249.
9. Merrill RM, Anderson AE, Merrill JG. Racial/ethnic differences in the use of surgery for ovarian cancer in the United States. Adv Med Sci. 2010;55(1):93-98.
10. Harlan LC, Clegg LX, Trimble EL. Trends in surgery and chemotherapy for women diagnosed with ovarian cancer in the United States. J Clin Oncol. 2003;21(18):3488-3494. (Pubitemid 46594082)
11. Kim S, Dolecek TA, Davis FG. Racial differences in stage at diagnosis and survival from epithelial ovarian cancer: a fundamental cause of disease approach. Social Sci Med. 2010;71(2):274-281.
12. Bristow RE, Paylis BE, Chi DS, Cliby WA. The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm. Gynecol Oncol. 2010;118(3):262-267.
13. Chase DM, Fedewa S, Chou TS, Chen A, Ward E, Brewster WR. Disparities in the allocation of treatment in advanced ovarian cancer: are there certain patient characteristics associated with nonstandard therapy? Obstet Gynecol. 2012;119(1):68-77.
14. Parham G, Phillips JL, Hicks ML, et al. The National Cancer Data Base report on malignant epithelial ovarian carcinoma in African-American women. Cancer. 1997;80(4):816-826. (Pubitemid 27339838)
15. Morgan RJ, Copeland L, Gershenson D, et al. Update of the NCCN ovarian cancer practice guidelines. Oncology. 1997;11:95-105. (Pubitemid 28011746)
16. Morgan R, Alvarez RD, Armstrong DK, et al. NCCN Practice Guidelines for Ovarian Cancer. Fort Washington, PA: NCCN; 2000.
17. Morgan R, Alvarez RD, Armstrong DK, et al. Ovarian Cancer Guidelines. Fort Washington, PA: NCCN; 2002.
18. Mercado C, Zingmond D, Karlan BY, et al. Quality of care in advanced ovarian cancer: the importance of provider specialty. Gynecol Oncol. 2010;117(1):18-22.
19. Barnholtz-Sloan JS, Tainsky MA, Abrams J, et al. Ethnic differences in survival among women with ovarian carcinoma. Cancer. 2002;94(6):1886-1893. (Pubitemid 34241128)
20. McGuire V, Jesser CA, Whittemore AS. Survival among U.S. women with invasive epithelial ovarian cancer. Gynecol Oncol. 2002;84(3):399-403. (Pubitemid 34211865)
21. McGuire V, Herrinton L, Whittemore AS. Race, epithelial ovarian cancer survival, and membership in a large health maintenance organization. Epidemiology. 2002;13(2):231-234. (Pubitemid 34160501)
22. Chan JK, Zhang M, Hu JM, Shin JY, Osann K, Kapp DS. Racial disparities in surgical treatment and survival of epithelial ovarian cancer in the United States. J Surg Oncol. 2008;97(2):103-107. (Pubitemid 351169035)
23. Aranda MA, McGory M, Sekeris E, Maggard M, Ko C, Zingmond DS. Do racial/ethnic disparities exist in the utilization of high-volume surgeons for women with ovarian cancer? Gynecol Oncol. 2008;111(2):166-172.
24. Bristow RE, Zahurak ML, Ibeanu OA. Racial disparities in ovarian cancer surgical care: a population-based analysis. Gynecol Oncol. 2011;121(2): 364-368.
25. Du XL, Sun CC, Milam MR, Bodurka DC, Fang S. Ethnic differences in socioeconomic status, diagnosis, treatment, and survival among older women with epithelial ovarian cancer. Int J Gynecol Cancer. 2008;18(4):660-669. (Pubitemid 352020170)
26. O'Malley CD, Cress RD, Campleman SL, Leiserowitz GS. Survival of Californian women with epithelial ovarian cancer, 1994-1996: a population-based study. Gynecol Oncol. 2003;91(3):608-615. (Pubitemid 38388159)
27. Terplan M, Smith EJ, Temkin SM. Race in ovarian cancer treatment and survival: a systematic review with meta-analysis. Cancer Causes Control. 2009;20(7):1139-1150.
28. Terplan M, Temkin S, Tergas A, Lengyel E. Does equal treatment yield equal outcomes? The impact of race survival in epithelial ovarian cancer. Gynecol Oncol. 2008;111(2):173-178.
29. Farley JH, Tian C, Rose GS, Brown CL, Birrer M, Maxwell GL. Race does not impact outcomes for advanced ovarian cancer patients treated with cisplatin/paclitaxel. Cancer. 2009;115(18):4210-4217.
30. Bristow RE, Ueda S, Gerardi MA, Ajiboye OB, Ibeanu OA. Analysis of racial disparities in stage IIIC epithelial ovarian cancer care and outcomes in a tertiary gynecologic oncology referral center. Gynecol Oncol. 2011;122(2):319-323.
31. Terplan M, Schluterman N, McNamara EJ, Tracy JK, Temkin SM. Have racial disparities in ovarian cancer increased over time? An analysis of SEER data. Gynecol Oncol. 2012;125(1):19-24.
32. Fairfield KM, Murray KM, Wierman HR, et al. Disparities in hospice care among older women dying with ovarian cancer. Gynecol Oncol. 2012;125(1):14-18.
33. Yang D, Khan S, Sun Y, et al. Association of BRCA1 and BRCA2 mutations with survival, chemotherapy sensitivity, and gene mutator phenotype in patients with ovarian cancer. JAMA. 2011;306(14):1557-1565.
34. Goff BA, Matthews BJ, Wynn M, Muntz HG, Lishner DM, Baldwin LM. Ovarian cancer: patterns of surgical care across the United States. Gynecol Oncol. 2006;103(2):383-390. (Pubitemid 44602199)
35. Cress RD, O'Malley CD, Leiserowitz GS, Campleman SL. Patterns of chemotherapy use for women with ovarian cancer: a population-based study. J Clin Oncol. 2003;21(8):1530-1535. (Pubitemid 46594106)
36. Thorpe KE, Howard D. Health insurance and spending among cancer patients. Health Aff (Millwood). 2003;W3(Suppl):189-198.
37. Balli S, Fey MF, H?ggi W, et al. Ovarian cancer: an institutional review of patterns of care, health insurance and prognosis. Eur J Cancer. 2000;36(16):2061-2068.
38. Goff BA, Matthews BJ, Larson EH, et al. Predictors of comprehensive surgical treatment in patients with ovarian cancer. Cancer. 2007;109(10):2031- 2042. (Pubitemid 46744198)
39. Fanning J, Gangestad A, Andrews SJ. National cancer data base/surveillance epidemiology and end results: potential insensitive-measure bias. Gynecol Oncol. 2000;77(3):450-453. (Pubitemid 30368566)
40. Winchester DP, Stewart AK, Phillips JL, Ward EE. The National Cancer Data Base: past, present, and future. Ann Surg Oncol. 2010(1);17:4-7.